The UK Health Security Agency (UKHSA) confirms additional cases of Clade Ib mpox.
One further case of Clade Ib mpox has been detected in a household contact of the first case, the UK Health Security Agency (UKSHA) can confirm.
This brings the total number of confirmed cases to 4, all of which belong to the same household.
The patient is currently under specialist care at Guy's and St Thomas' NHS Foundation Trust in London. The risk to the UK population remains low.
The patient has been isolating since identified as a contact of the first case and no additional contact tracing is required.
Professor Susan Hopkins, Chief Medical Adviser at UKHSA, said:
Mpox is very infectious in households with close contact and so it is not unexpected to see further cases within the same household.
The overall risk to the UK population remains low. We are working with partners to make sure all contacts of the cases are identified and contacted to reduce the risk of further spread.
Contacts of cases are being followed up by UKHSA and partner organisations. All contacts will be offered testing and vaccination as needed and advised on any necessary further care if they have symptoms or test positive.
There has been extensive planning underway to ensure healthcare professionals are equipped and prepared to respond to any further confirmed cases.
Previous
4 November 2024
Two cases of Clade Ib mpox have been detected in household contacts of the first case, the UK Health Security Agency (UKSHA) can confirm. This brings the total number of confirmed cases to 3.
The 2 patients are currently under specialist care at Guy's and St Thomas' NHS Foundation Trust in London. The risk to the UK population remains low.
There has been extensive planning underway to ensure healthcare professionals are equipped and prepared to respond to any further confirmed cases.
Professor Susan Hopkins, Chief Medical Adviser at UKHSA, said:
Mpox is very infectious in households with close contact and so it is not unexpected to see further cases within the same household.
The overall risk to the UK population remains low. We are working with partners to make sure all contacts of the cases are identified and contacted to reduce the risk of further spread.
Contacts of all 3 cases are being followed up by UKHSA and partner organisations. All contacts will be offered testing and vaccination as needed and advised on any necessary further care if they have symptoms or test positive.
30 October 2024
The UK Health Security Agency (UKHSA) has detected a single confirmed human case of Clade Ib mpox. The risk to the UK population remains low.
This is the first detection of this Clade of mpox in the UK. It is different from mpox Clade II that has been circulating at low levels in the UK since 2022, primarily among gay, bisexual and other men-who-have-sex-with-men (GBMSM).
UKHSA, the NHS and partner organisations have well tested capabilities to detect, contain and treat novel infectious diseases, and while this is the first confirmed case of mpox Clade Ib in the UK, there has been extensive planning underway to ensure healthcare professionals are equipped and prepared to respond to any confirmed cases.
The case was detected in London and the individual has been transferred to the Royal Free Hospital High Consequence Infectious Diseases unit. They had recently travelled to countries in Africa that are seeing community cases of Clade Ib mpox. The UKHSA and NHS will not be disclosing any
